BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

Clover Health (CLOV)Clover HealthCompany update

Star ratings support Clover’s continued ability to offer market-leading and low out-of-pocket costs for members WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for

Related news

CLOVClover Health2026-10-01 12:00 EST

Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value

CLOVClover Health2026-10-19 20:30 EST

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-11-04 21:05 EST

Clover Health Reports Third Quarter 2026 Results

CLOVClover Health2026-10-26 20:05 EST

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

CLOVClover Health2026-10-19 20:30 EST

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

CLOVClover Health2026-10-08 22:45 EST

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

CLOVClover Health2026-10-07 20:05 EST

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Stock data

Close
4.48 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States